Untested formulations Semaglutide and tirzepatide are FDA-approved as injectables (an oral tablet version of semaglutide is also approved), but the formulations some drug compounding pharmacies are selling in the form of sublingual drops or dissolving tablets have never been studied in clinical trials
Possible Orlistat side effects include gas, increased bowel movements, and fecal incontinence
GLP-1 receptor agonists stimulate insulin secretion from pancreatic beta cells in a glucose-dependent mannermeaning they only promote insulin release when blood glucose levels are elevated, which significantly reduces the risk of hypoglycaemia compared with some other diabetes medicines
Injecting through wet alcohol can push residue into your solution
COA verification, batch testing, and storage matter
Helps reduce unnecessary snacking, improve portion control for women and men